BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection

Earlier detection of cancer enables intervention when it is more likely to be treatable and curable, resulting in improved patient outcomes, such as the reduction of morbidity and mortality. Analysis of the National Cancer Institute's Surveillance, Epidemiology, and End Results data revealed that cancers diagnosed after distant metastasis represent ~18% of all diagnoses and close to half of all deaths.1 Reducing the proportion of cancers diagnosed at late stages is therefore critical for reducing the global burden of cancer mortality.

Click here for the full article.

Previous
Previous

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests

Next
Next

Creating Standards for Liquid Biopsies: the BLOODPAC Experience